Endoscopic Proximal Hamstring Repairs Remain Safe and Beneficial With High Patient Satisfaction at a Minimum of 6-Year Follow-Up.

Abstract

To evaluate midterm outcomes of endoscopic proximal hamstring repair in a previously established cohort. A retrospective study design was used for a midterm (minimum 6 years) follow-up time. Patients completed the questionnaires over the phone or electronically on REDCap after consent. The questionnaires included the modified Harris Hip Score, the Hip Outcome (HOS), the Sports Subscale (HOS-SSS), the Single Assessment Numeric Evaluation, the International Hip Outcome Tool-12, VAS pain scale, and queried on satisfaction with the surgery. Descriptive statistics including mean and variance were used to analyze the results and compare values preoperatively and at the midterm time point. Twenty two of 29 individuals participated (75.8%). Minimum follow-up time was 6.2 years with a maximum follow-up time of 10.6 years (mean 7.6, SD 1.08). Subjects reported a mean modified Harris Hip Score of 82.6 (SD 17.1, range 46.2-100.1), mean HOS of 83.2 (SD 19.9, range 33.8-100), mean HOS-SSS of 89.2 (SD 15, range 50-100, n = 12), mean Single Assessment Numeric Evaluation of 80.2% (SD 20.6, range 30-100%), mean the International Hip Outcome Tool-12 of 79.5 (SD 22.7, range 32.5-100), mean pain score of 1.7 (SD 2.4, range 0-7), and 86.4% satisfaction with the surgery. Endoscopic hamstring repair remains beneficial with high patient satisfaction (86.4%, n = 22) and patient-reported outcome scores (85.7% reaching acceptable symptom state, n = 21) at midterm follow-up. Level IV, retrospective case series.